These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38106273)

  • 21. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
    Zhang H; Sun FH; Chen ZC; Wang Q
    Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
    [No Abstract]   [Full Text] [Related]  

  • 22. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
    Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
    Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer.
    Tsutani Y; Shimada Y; Ito H; Miyata Y; Ikeda N; Nakayama H; Okada M
    Front Oncol; 2021; 11():622742. PubMed ID: 34164334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
    Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
    Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.
    Jeon HW; Kim YD; Kim KS; Sung SW; Park HJ; Park JK
    World J Surg Oncol; 2014 Jul; 12():215. PubMed ID: 25027055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Ann Surg Oncol; 2021 Apr; 28(4):2068-2075. PubMed ID: 32946014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
    Aragaki M; Kato T; Fujiwara-Kuroda A; Hida Y; Kaga K; Wakasa S
    J Cardiothorac Surg; 2020 Aug; 15(1):229. PubMed ID: 32859238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study.
    Zhong C; Sakurai H; Wei S; Fang W; Asamura H
    J Thorac Dis; 2018 Feb; 10(2):991-998. PubMed ID: 29607172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis for Pneumonic-Type Invasive Mucinous Adenocarcinoma in a Single Lobe on CT: Is It Reasonable to Designate It as Clinical T3?
    Kim W; Lee SM; Lee JB; Seo JB; Kim HK; Kim J; Lee HY
    Korean J Radiol; 2022 Mar; 23(3):370-380. PubMed ID: 35213098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
    Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ
    Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Added prognostic value of CT characteristics and IASLC/ATS/ERS histologic subtype in surgically resected lung adenocarcinomas.
    Suh YJ; Lee HJ; Kim YT; Kang CH; Park IK; Jeon YK; Chung DH
    Lung Cancer; 2018 Jun; 120():130-136. PubMed ID: 29748007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
    Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
    Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment.
    Jeon YJ; Lee J; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Choi YL; Kim HK
    Lung Cancer; 2022 Jun; 168():21-29. PubMed ID: 35462111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.